posted on 2019-08-27, 15:21authored byK Hosaka, Y Yang, T Seki, C Fischer, O Dubey, E Fredlund, J Hartman, P Religa, H Morikawa, Y Ishii, M Sasahara, O Larsson, G Cossu, R Cao, S Lim, Y Cao
Vascular pericytes, an important cellular component in the tumor microenvironment, are often associated with tumor vasculatures, and their functions in cancer invasion and metastasis are poorly understood. Here we show that PDGF-BB induces pericyte-fibroblast transition (PFT), which significantly contributes to tumor invasion and metastasis. Gain- and loss-of-function experiments demonstrate that PDGF-BB-PDGFRβ signaling promotes PFT both in vitro and in in vivo tumors. Genome-wide expression analysis indicates that PDGF-BB-activated pericytes acquire mesenchymal progenitor features. Pharmacological inhibition and genetic deletion of PDGFRβ ablate the PDGF-BB-induced PFT. Genetic tracing of pericytes with two independent mouse strains, TN-AP-CreERT2:R26R-tdTomato and NG2-CreERT2:R26R-tdTomato, shows that PFT cells gain stromal fibroblast and myofibroblast markers in tumors. Importantly, coimplantation of PFT cells with less-invasive tumor cells in mice markedly promotes tumor dissemination and invasion, leading to an increased number of circulating tumor cells and metastasis. Our findings reveal a mechanism of vascular pericytes in PDGF-BB-promoted cancer invasion and metastasis by inducing PFT, and thus targeting PFT may offer a new treatment option of cancer metastasis.
Funding
Swedish Research Council, the Swedish
Cancer Foundation, the Karolinska Institute Foundation, a Karolinska Institute distinguished professor award, the Torsten Soderbergs Foundation,
the Tore Nilsons Foundation, the Ruth and Richard Julin Foundation, the
Ogonfonden Foundation, the Martin Rinds Foundation, the Maud and
Birger Gustavssons Foundation, the Lars Hiertas Minne Foundation, the
Alex and Eva Wallströms Foundation, the Robert Lundbergs Memorial
Foundation, the Swedish Diabetes Foundation, the Swedish Children Cancer Foundation, European Research Council Advanced Grant ANGIOFAT
(Project 250021), the Knut Alice Wallenberg Foundation, and an advanced
grant from NOVO Nordisk Foundation.
History
Citation
Proceedings of the National Academy of Sciences of the USA, 113 (38), pp. E5618-E5627
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular Sciences
Version
VoR (Version of Record)
Published in
Proceedings of the National Academy of Sciences of the USA
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1608384113/-/DCSupplemental.The sequences reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession nos.
GSE85955 and GSE33717).